Close
Shopping Cart
Your Cart is Empty

What is Marginal Zone Lymphoma?

Marginal Zone Lymphoma (MZL) is a group of slow growing Non-Hodgkins Lymphoma (NLH) B-cell lymphomas, which account for approximately eight percent of all NHL cases. The average age at diagnosis is 60 years, and it is slightly more common in women than in men. Linda Anne Bentz Parsons, had a type of MZL called Splenic MZL with Hemolitic Anemia. Splenic MZL occurs most often in the spleen and blood. Bone marrow and blood involvement are usually present in 95% in SMZL with villous lymphocytes present in blood in 15% of cases. But the precise pathogenesis of SMZL is unknown. The Hemolytic Anemia portion can be explained like thisThe destruction of red blood cells is called hemolysis. And anemia is a lower than normal amount of red blood cells . In Hemolytic Anemia, the red blood cells are destroyed faster than they can be made. Essentially  the blood cells create antibodies, making the body think that it's own blood cells are an "intruder", and the blood cells destroy themselves.